Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis (Journal article)

Boletis, J. N./ Ioannidis, J. P./ Boki, K. A./ Moutsopoulos, H. M.

Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous immunoglobulin maintained remission over 18 months, similar to standard intravenous cyclophosphamide treatment. Pulsed immunoglobulin may be a useful alternative therapy in lupus nephritis.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adolescent,Adult,Cyclophosphamide/*therapeutic use,Drug Administration Schedule,Female,Humans,Immunoglobulins, Intravenous/*therapeutic use,Immunosuppressive Agents/*therapeutic use,Injections, Intravenous,Lupus Erythematosus, Systemic/drug therapy,Lupus Nephritis/*drug therapy,Male,Middle Aged,Pilot Projects,Treatment Outcome
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/20657
ISSN: 0140-6736
Link: http://www.ncbi.nlm.nih.gov/pubmed/10470708
http://ac.els-cdn.com/S0140673699015755/1-s2.0-S0140673699015755-main.pdf?_tid=be3a226a6b4f5a61a9ead48527484a4d&acdnat=1333364734_f8fdf130d6fa387ceb2204746b7f3592
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Boletis-1999-Intravenous immunogl.pdf37.83 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20657
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.